Drug Profile
TCM 606F
Latest Information Update: 28 Mar 2019
Price :
$50
*
At a glance
- Originator TCM Biotech International
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-alcoholic fatty liver disease
Most Recent Events
- 28 Mar 2019 No recent reports of development identified for clinical-Phase-Unknown development in Non-alcoholic-fatty-liver-disease in Taiwan
- 22 Feb 2016 Clinical trials in Non-alcoholic fatty liver disease in Taiwan (unspecified route) before February 2016
- 22 Feb 2016 TCM Biotech International completes a clinical trial in Non-alcoholic fatty liver disease in Taiwan (TCM Biotech International website, February 2016)